NCT06862271

Brief Summary

Urogenital surgery is one of the most frequently performed surgical procedures in the pediatric patient population. There is no consensus on which analgesic method is most effective for pain control in these patients. In clinical practice, if there are no contraindications, caudal block or penile block combined with intravenous fentanyl can be preferred as an analgesic method. In this study, the results of these two analgesia methods will be compared with the research.Randomly selected participants will be compared by looking at parameters such as postoperative questionnaire results, walking time and urination time.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 28, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 6, 2025

Completed
26 days until next milestone

Study Start

First participant enrolled

April 1, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2025

Completed
Last Updated

March 11, 2025

Status Verified

March 1, 2025

Enrollment Period

3 months

First QC Date

February 28, 2025

Last Update Submit

March 6, 2025

Conditions

Keywords

pediatric urologic surgeriespediatric deliriumcaudal blockpenile blockFLACC ScalePAED Scale

Outcome Measures

Primary Outcomes (1)

  • Pediatric Anesthesia Emergence Delirium (PAED) Scale

    The PAED scale will be used to assess post-anesthesia emergence agitation. This scale was defined in 2004 and is considered the standard for diagnosing emergence agitation. The scale, consisting of five statements (from "child makes eye contact" to "child cannot be comforted") is rated from 1 to 4, with a maximum score of 20. Patients are observed for each of the 5 symptoms of delirium. After an observation is completed, the clinician subjectively scores the severity of that delirium symptom using the Lickert scale ("not at all," "only a little," "quite a bit," "very much," and "extremely"). A total score of 10 or more may be consistent with delirium urgent. As the score increases, a score of ≥10 points indicates 64% sensitivity and 86% specificity for delirium, while a score of \>12 points provides 100% sensitivity and 94.5% specificity for the diagnosis of emergency delirium (ED).

    The first evaluation will be made after extubation, the second evaluation will be made at the 15th minute after surgery.

Secondary Outcomes (2)

  • Face Leg Activity Cry Consolability (FLACC) Scale

    The first evaluation will be made after extubation, the second evaluation will be made at the 15th minute after surgery.

  • LİKERT Scale

    24th hour after surgery

Study Arms (2)

Group 1 ( Caudal block group )

ACTIVE COMPARATOR

In the caudal block group, after the induction of caudal block with investigations, 0.2% bupivacaine will be applied to the epidural space in a volume of 0.8 mL/kg and a maximum of 20 mL will be injected into the epidural space and the surgical incision will be made at the 15th minute.

Procedure: Group 1 ( Caudal block group )

Group 2 (Penile block and IV Fentanyl group)

ACTIVE COMPARATOR

In the penile block and IV fentanyl group, 1 µg/kg fentanyl will be administered by the investigations and 5 minutes later, penile block will be performed using 0.25% bupivacaine at a dose of 0.2 mL/kg.

Procedure: Group 2 (Penile block and IV Fentanyl group)

Interventions

In the caudal block group, after the induction of caudal block with investigations, 0.2% bupivacaine will be applied to the epidural space in a volume of 0.8 mL/kg and a maximum of 20 mL will be injected into the epidural space and the surgical incision will be made at the 15th minute. For participants after surgery, Pediatric Anesthesia Emergence Delirium (PAED), Face Leg Activity Cry Consolability (FLACC) scales will be recorded, and for parental satisfaction, the LIKERT scale will be used. In addition, the child's walking time, first urination time, and need for additional painkillers will be questioned and recorded.

Group 1 ( Caudal block group )

In the penile block and IV fentanyl group, 1 µg/kg fentanyl will be administered by the investigations and 5 minutes later, penile block will be performed using 0.25% bupivacaine at a dose of 0.2 mL/kg. For participants after surgery, Pediatric Anesthesia Emergence Delirium (PAED), Face Leg Activity Cry Consolability (FLACC) scales will be recorded, and for parental satisfaction, the LIKERT scale will be used. In addition, the child's walking time, first urination time, and need for additional painkillers will be questioned and recorded.

Group 2 (Penile block and IV Fentanyl group)

Eligibility Criteria

Age4 Months - 12 Years
Sexmale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • months - 12 years old male patient
  • Acceptance of participation in the study
  • Patients Planned for Urogenital Surgery
  • ASA I-II Patients

You may not qualify if:

  • \<4 months, \>12 years male patient
  • Female patient
  • Not accepted to be included in the study
  • ASA status III-IV
  • History of bleeding disorder
  • Spinal cord disease
  • Obstructive sleep apnea
  • Developmental delay
  • Behavioral disorder
  • Allergy to any drug in the protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Etlik City Hospital

Yenimahalle, Ankara, 06100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Miray G Özdemir, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Specialist / Doctor

Study Record Dates

First Submitted

February 28, 2025

First Posted

March 6, 2025

Study Start

April 1, 2025

Primary Completion

June 30, 2025

Study Completion

July 15, 2025

Last Updated

March 11, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations